Market Value364,337,000
Total Holdings41
File Date2022-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BEAM / Beam Therapeutics Inc.
LPTX / Leap Therapeutics, Inc.
SKIL / Skillsoft Corp.
STTK / Shattuck Labs, Inc.
AVAH / Aveanna Healthcare Holdings Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
CCXI / ChemoCentryx Inc
GATO / Gatos Silver, Inc.
CRSP / CRISPR Therapeutics AG
GH / Guardant Health, Inc.
TCDA / Tricida Inc
HZNP / Horizon Therapeutics Plc
FGEN / FibroGen, Inc.
BLU / Bellus Health Inc
ACET / Adicet Bio, Inc.
AKRO / Akero Therapeutics, Inc.
RXDX / Prometheus Biosciences Inc
GSK / GSK plc - Depositary Receipt (Common Stock)
MRVI / Maravai LifeSciences Holdings, Inc.
EW / Edwards Lifesciences Corporation
AVPT / AvePoint, Inc.
UP / Wheels Up Experience Inc.
/ VENTYX BIOSCIENCES INC
DOMA / Doma Holdings Inc.
EVH / Evolent Health, Inc.
MMM / 3M Company
ADV / Advantage Solutions Inc.
MKFG / Markforged Holding Corporation
RVMD / Revolution Medicines, Inc.
LSAQ / LifeSci Acquisition II Corp
CVM / CEL-SCI Corporation
LEV / The Lion Electric Company
ALLK / Allakos Inc.
ITCI / Intra-Cellular Therapies, Inc.
KZR / Kezar Life Sciences, Inc.
NKTR / Nektar Therapeutics
ME / 23andMe Holding Co.
XENE / Xenon Pharmaceuticals Inc.
NLY / Annaly Capital Management, Inc.
JAZZ / Jazz Pharmaceuticals plc
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
MRTX / Mirati Therapeutics, Inc.
RIG / Transocean Ltd.
BLCO / Bausch + Lomb Corporation
ACLX / Arcellx, Inc.
NBIX / Neurocrine Biosciences, Inc.
TVTX / Travere Therapeutics, Inc.
ALGS / Aligos Therapeutics, Inc.
ALLO / Allogene Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.
SKIN / The Beauty Health Company
XFOR / X4 Pharmaceuticals, Inc.
NG / NovaGold Resources Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
EOLS / Evolus, Inc.
LLY / Eli Lilly and Company
CTLT / Catalent, Inc.
PTGX / Protagonist Therapeutics, Inc. Call
ISEE / IVERIC bio Inc
REGN / Regeneron Pharmaceuticals, Inc.
ATXS / Astria Therapeutics, Inc.
SAVA / Cassava Sciences, Inc. Call
BIIB / Biogen Inc.
CHRS / Coherus Oncology, Inc.
CLDX / Celldex Therapeutics, Inc.
ALT / Altimmune, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
PCVX / Vaxcyte, Inc.
INSP / Inspire Medical Systems, Inc.
STVN / Stevanato Group S.p.A.
FEMY / Femasys Inc.
NTRA / Natera, Inc.